Furthermore, we will need to examine whether pharmacological RAGE inhibition replicates these effects in human models of obesity and whether tissue-specific RAGE deletion reveals differential metabolic outcomes. Here, AGER is linked to obesity due to melanocortin 4 receptor deficiency.